Reuters logo
BRIEF-Abivax initiates clinical trial (ABX464-005) to evaluate effect of ABX464 on HIV-reservoirs in HIV patients
2017年4月4日 / 下午4点43分 / 6 个月前

BRIEF-Abivax initiates clinical trial (ABX464-005) to evaluate effect of ABX464 on HIV-reservoirs in HIV patients

April 4 (Reuters) - Abivax SA:

* Initiates clinical trial (ABX464-005) to evaluate the effect of ABX464 on HIV-reservoirs in HIV patients

* Initial results are expected in Q3 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below